Literature DB >> 9433435

Maintaining abstinence from alcohol with gamma-hydroxybutyric acid.

G Addolorato, M Cibin, E Capristo, F Beghe, G Gessa, G F Stefanini, G Gasbarrini, E Caprista.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9433435     DOI： 10.1016/s0140-6736(05)78088-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Management of alcohol dependence in patients with liver disease.

Authors:  Giovanni Addolorato; Antonio Mirijello; Lorenzo Leggio; Anna Ferrulli; Raffaele Landolfi
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

Review 2.  Pharmacotherapy for alcoholic patients with alcoholic liver disease.

Authors:  Cynthia L Vuittonet; Michael Halse; Lorenzo Leggio; Samuel B Fricchione; Michael Brickley; Carolina L Haass-Koffler; Tonya Tavares; Robert M Swift; George A Kenna
Journal:  Am J Health Syst Pharm       Date:  2014-08-01       Impact factor: 2.637

Review 3.  [Gamma-hydroxybutyrate--a neurotransmitter, medicine, and drug].

Authors:  G Trendelenburg; A Ströhle
Journal:  Nervenarzt       Date:  2005-07       Impact factor: 1.214

4.  Spontaneous and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons.

Authors:  Elise M Weerts; Amy K Goodwin; Roland R Griffiths; P Rand Brown; Wolfgang Froestl; Cornelis Jakobs; K Michael Gibson
Journal:  Psychopharmacology (Berl)       Date:  2005-01-12       Impact factor: 4.530

5.  Anti-Alcohol and Anxiolytic Properties of a New Chemical Entity, GET73.

Authors:  Antonella Loche; Francesco Simonetti; Carla Lobina; Mauro A M Carai; Giancarlo Colombo; M Paola Castelli; Domenico Barone; Roberto Cacciaglia
Journal:  Front Psychiatry       Date:  2012-02-14       Impact factor: 4.157

6.  Repurposing of substances with lactone moiety for the treatment of γ-Hydroxybutyric acid and γ-Butyrolactone intoxication through modulating paraoxonase and PPARγ.

Authors:  Sepand Tehrani Fateh; Amir Salehi-Najafabadi
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.